Large-Scale Phenome-Wide Association Study of PCSK9 Variants Demonstrates Protection Against Ischemic Stroke.

Circulation. Genomic and Precision Medicine
Abhiram S RaoErik Ingelsson

Abstract

PCSK9 inhibition is a potent new therapy for hypercholesterolemia and cardiovascular disease. Although short-term clinical trial results have not demonstrated major adverse effects, long-term data will not be available for some time. Genetic studies in large biobanks offer a unique opportunity to predict drug effects and provide context for the evaluation of future clinical trial outcomes. We tested the association of the PCSK9 missense variant rs11591147 with predefined phenotypes and phenome-wide, in 337 536 individuals of British ancestry in the UK Biobank, with independent discovery and replication. Using a Bayesian statistical method, we leveraged phenotype correlations to evaluate the phenome-wide impact of PCSK9 inhibition with higher power at a finer resolution. The T allele of rs11591147 showed a protective effect on hyperlipidemia (odds ratio, 0.63±0.04; P=2.32×10-38), coronary heart disease (odds ratio, 0.73±0.09; P=1.05×10-6), and ischemic stroke (odds ratio, 0.61±0.18; P=2.40×10-3) and was associated with increased type 2 diabetes mellitus risk adjusted for lipid-lowering medication status (odds ratio, 1.24±0.10; P=1.98×10-7). We did not observe associations with cataracts, heart failure, atrial fibrillation, and c...Continue Reading

References

May 29, 1975·The New England Journal of Medicine·B R HornA Van Kessel
May 6, 2003·Nature Genetics·Marianne AbifadelCatherine Boileau
Jan 17, 2004·Human Genetics·Kirsten M TimmsDonna M Shattuck
Aug 24, 2004·American Journal of Epidemiology·Carolyn M HutterSteve E Humphries
Jan 18, 2005·Stroke; a Journal of Cerebral Circulation·Mark FisherJohn Norris
Mar 24, 2006·The New England Journal of Medicine·Jonathan C CohenHelen H Hobbs
Feb 10, 2009·Nature Genetics·Daniel F GudbjartssonKari Stefansson
Feb 14, 2013·Primary Care·Robert H Nelson
Sep 19, 2014·European Journal of Preventive Cardiology·Judith A Finegold, Darrel P Francis
Mar 17, 2015·The New England Journal of Medicine·Jennifer G RobinsonUNKNOWN ODYSSEY LONG TERM Investigators
Mar 17, 2015·The New England Journal of Medicine·Marc S SabatineUNKNOWN Open-Label Study of Long-Term Evaluation against LDL Cholesterol (OSLER) Investigators
May 12, 2015·Nature Genetics·Ida SurakkaUNKNOWN ENGAGE Consortium
Jun 20, 2015·Journal of the American College of Cardiology·Robert P Giugliano, Marc S Sabatine
Nov 14, 2015·Global Cardiology Science & Practice·Mohamed Hassan
Jul 2, 2016·European Journal of Internal Medicine·Haralampos MilionisMoses Elisaf
Oct 5, 2016·JAMA : the Journal of the American Medical Association·Luca A LottaNicholas J Wareham
Oct 13, 2016·European Journal of Internal Medicine·Luis Castilla-Guerra, M C Fernandez-Moreno
Dec 3, 2016·The Lancet. Diabetes & Endocrinology·Amand F SchmidtNaveed Sattar
Dec 14, 2016·The New England Journal of Medicine·Brian A FerenceMarc S Sabatine
Mar 18, 2017·The New England Journal of Medicine·Marc S SabatineUNKNOWN FOURIER Steering Committee and Investigators
May 19, 2017·Clinical Chemistry·Erik Ingelsson, Joshua W Knowles
Aug 17, 2017·The New England Journal of Medicine·Robert P GiuglianoUNKNOWN EBBINGHAUS Investigators
Oct 12, 2017·European Heart Journal·Jemma C HopewellUNKNOWN METASTROKE Collaboration of the ISGC

❮ Previous
Next ❯

Citations

Jul 13, 2018·Circulation. Genomic and Precision Medicine·David SullivanTony Keech
Nov 28, 2018·European Journal of Preventive Cardiology·Chiara MacchiMassimiliano Ruscica
Feb 1, 2019·Circulation Research·Robert S RosensonWolfgang Koenig
Mar 19, 2019·Current Opinion in Hematology·Milagros C RomayM Luisa Iruela-Arispe
Nov 13, 2019·Annals of Neurology·Dylan M WilliamsAroon D Hingorani
Mar 13, 2019·Nature Medicine·Luanluan SunUNKNOWN Regional Co-ordinating Centres
Aug 21, 2020·Proceedings of the National Academy of Sciences of the United States of America·Michael WainbergNathan D Price
Feb 19, 2019·NPJ Genomic Medicine·Maya S SafarovaIftikhar J Kullo
Jul 28, 2020·JAMA Neurology·Aristeidis H Katsanos, Robert G Hart
Oct 24, 2019·NAR Genomics and Bioinformatics·Virag Sharma, Michael Hiller
Nov 25, 2020·Journal of Atherosclerosis and Thrombosis·Hayato TadaMasa-Aki Kawashiri
May 21, 2021·Nature·Kiran MusunuruSekar Kathiresan
Jul 18, 2021·Journal of Medical Genetics·Lijuan WangXue Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

European Heart Journal
Jemma C HopewellMETASTROKE Collaboration of the ISGC
Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Rebecca N JeromeJoshua C Denny
Current Atherosclerosis Reports
Larry B Goldstein
Circulation. Genomic and Precision Medicine
Sander W van der LaanGerard Pasterkamp
© 2022 Meta ULC. All rights reserved